Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 3163-3168, June 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eddy, E. P.
Right arrow Articles by Rosenkranz, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eddy, E. P.
Right arrow Articles by Rosenkranz, H. S.

Mutagenicity, Unscheduled DNA Synthesis, and Metabolism of 1-Nitropyrene in the Human Hepatoma Cell Line HepG21

E. Priyadarshini Eddy2, Paul C. Howard, G. David McCoy and Herbert S. Rosenkranz

Department of Environmental Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106

The cell line HepG2 is derived from a well differentiated human hepatoblastoma, which retains many of the morphological characteristics of liver parenchymal cells. These cells at passages >95 were found to metabolically activate carcinogens to genotoxic metabolites. The addition of 6.8 µM 1-methyl-3-nitro-1-nitrosoguanidine, 5.3 µM 4-nitroquinoline-N-oxide, and 4-20.3 µM 1-nitropyrene resulted in the induction of mutations at the HGPRT locus as determined by 6-thioguanine resistance. This is the first description of the induction of mutations in these cells. Additionally, unscheduled DNA synthesis in the presence of 4 mM hydroxyurea was increased by 9% with 5.3 µM 4-nitroquinoline-N-oxide, 57% with 13.6 µM 1-methyl-3-nitro-1-nitrosoguanidine, and 300% with 8.2 µM 1-nitropyrene. High performance liquid chromatographic analysis of metabolites formed following incubation of HepG2 with either [3H]-1-nitropyrene or [14C]benzo(a)pyrene demonstrate the occurrence of arene oxidation as well as nitroreduction.

1 Supported by the NIH, with Grant ES 03648 to P. C. H., Grant CA 32126 to G. D. M., and Grant ES 02827 to H. S. R.

2 To whom requests for reprints should be addressed.

Received 12/ 1/86. Revised 3/10/87. Accepted 3/19/87.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y.-H. Chae, T. Thomas, F. P. Guengerich, P. P. Fu, and K. El-Bayoumy
Comparative Metabolism of 1-, 2-, and 4-Nitropyrene by Human Hepatic and Pulmonary Microsomes
Cancer Res., April 1, 1999; 59(7): 1473 - 1480.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.